{"id":"W1958688023","doi":"10.1111/hiv.12029","title":"Pharmacokinetics of the combination raltegravir/atazanavir in <scp>HIV</scp>‐1‐infected patients","year":2013,"lang":"en","type":"article","venue":"HIV Medicine","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"Radboud Universiteit","keywords":"Raltegravir; Atazanavir; Emtricitabine; Lamivudine; Medicine; Regimen; Pharmacology; Pharmacokinetics; Nucleoside Reverse Transcriptase Inhibitor; Viral load; Internal medicine; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001660252,0.0002084491,0.000399214,0.0002120662,0.0000464115,0.000004606095,0.0001374284,0.00007417426,0.0002725684],"category_scores_gemma":[0.0004572941,0.000122121,0.00005895112,0.0006010898,0.0001578749,0.00007554911,0.00005491404,0.0002223437,0.0001824395],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001002167,"about_ca_system_score_gemma":0.00006528029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006683818,"about_ca_topic_score_gemma":0.00001137867,"domain_scores_codex":[0.9983896,0.00008015376,0.0004939082,0.0002222858,0.0005435555,0.0002704745],"domain_scores_gemma":[0.9989374,0.000202367,0.000180525,0.0003064622,0.0002428858,0.0001303043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00001592355,0.0008380362,0.8746782,0.00009649612,0.00008031906,0.000009647416,0.001925789,0.000002619263,0.003016707,0.0001882057,0.1150678,0.004080237],"study_design_scores_gemma":[0.01334274,0.0002016142,0.9588121,0.0005150017,0.0001872943,0.00000538616,0.0003720862,0.0004867726,0.005937348,0.0001757696,0.01990001,0.00006390447],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805332,0.0001830578,0.00003010754,0.007618662,0.0002824964,0.001203593,0.000008840375,0.0000369547,0.01010311],"genre_scores_gemma":[0.9845973,0.0001114264,0.0001617576,0.0004972105,0.00007267884,0.00006329988,0.0002914518,0.0000236427,0.01418123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09516781,"threshold_uncertainty_score":0.4979949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01006250946183429,"score_gpt":0.2496838622939348,"score_spread":0.2396213528321005,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}